Serious infections are increasing among psoriasis inpatients
SCOTTSDALE, ARIZ. – From enterocolitis to MRSA, serious infections are on the rise among inpatients with psoriasis, and psoriasis is an independent risk factor for serious infections, according to findings from large retrospective studies from the United States and the United Kingdom.
Inpatients... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 16, 2016 Category: Dermatology Source Type: news
Crisaborole’s safety holds up in long-term atopic dermatitis trial
SCOTTSDALE, ARIZ. – The phosphodiesterase-4 inhibitor crisaborole was well tolerated over 6 to 12 months, yielding no major safety signals during a multicenter, open-label extension study of patients with mild-to-moderate atopic dermatitis.
These safety results held up across age groups and over... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 14, 2016 Category: Dermatology Source Type: news
Mastering MACRA: How to thrive under new payment models
As MACRA makes quality-based care the law of the land, don’t just glide under the new expectations, thrive. That advice comes from accountable care experts who are seeing firsthand the tools leading to success in the new payment landscape.
Rule No. 1: Step up to the plate, said Julian D. “Bo”... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 13, 2016 Category: Dermatology Source Type: news
Atopic dermatitis increases risk of ADHD, comorbidities add to it
Atopic dermatitis (AD) is associated with an increased risk for attention-deficit/hyperactivity disorder (ADHD) in children and adults, and a host of factors and comorbid conditions increase this risk, according to a study published in the British Journal of Dermatology.
Mark A. Strom and his... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 13, 2016 Category: Dermatology Source Type: news
Decision Support in Medicine: Rosacea
1. Are you confident of the diagnosis?Characteristic findings on physical examinationPrimary clinical features (one or more) include: flushing, nontransient erythema, papules, and pustules and telangiectasias usually in a central facial distribution. ... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 13, 2016 Category: Dermatology Source Type: news
Study lays groundwork for refractory cutaneous lupus treatment algorithms
SCOTTSDALE, ARIZ. – Thalidomide, methotrexate, dapsone, and belimumab may be the best treatment alternatives for cutaneous lupus erythematosus that is refractory to antimalarials, based on reviews of 15 years of medical records from three large tertiary care centers.
The study is the largest so... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 13, 2016 Category: Dermatology Source Type: news
Infantile hemangiomas clear faster with Nd:YAG treatment
BOSTON – Using a 650-microsecond, pulsed 1064nm neodymium-doped yttrium aluminum garnet (Nd:YAG) laser to treat infantile hemangiomas can yield high clearance rates after one treatment, without adverse reactions, according to a study presented at the annual meeting of the American Society for Laser... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 11, 2016 Category: Dermatology Source Type: news
FDA: Olanzapine can cause serious skin reaction
Olanzapine can cause a rare but serious skin reaction that can affect other parts of the body, according to a Food and Drug Administration safety alert released May 10.
The condition linked to all products containing the second-generation antipsychotic is called Drug Reaction with Eosinophilia and... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 11, 2016 Category: Dermatology Source Type: news
New Dermatology News board members
(Source: Skin and Allergy News)
Source: Skin and Allergy News - May 10, 2016 Category: Dermatology Source Type: news
Macitentan falls short to stop digital ulcers in systemic sclerosis
Macitentan failed to reduce digital ulcers in systemic sclerosis patients in a pair of randomized trials including approximately 500 adults. The findings were published online May 10 in JAMA.
Digital ulcers occur in 35%-68% of systemic sclerosis patients, and endothelin-1 (ET-1) has demonstrated... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 10, 2016 Category: Dermatology Source Type: news
TRACTISS ends rituximab hopes for Sjögren’s syndrome
GLASGOW – Rituximab is unlikely to work as a treatment for Sjögren’s syndrome, according to a sneak peak of results from a multicenter study.
The study, the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren’s Syndrome (TRACTISS), showed that there were no significant differences... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 9, 2016 Category: Dermatology Source Type: news
MRSA prevalence in asymptomatic athletes comparable to dialysis, HIV patients
The prevalence of methicillin-resistant Staphylococcus aureus colonization among asymptomatic athletes is more than three times higher than the rate reported for the community population overall, a systematic review and meta-analysis showed.
Investigators searched PubMed and EMBASE looking... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 8, 2016 Category: Dermatology Source Type: news
Brodalumab effective for rare, severe types of psoriasis
The investigational interleukin-17 inhibitor brodalumab was safe and effective in a small phase III Japanese study of adults with two rare and severe types of psoriasis, generalized pustular psoriasis (GPP) and psoriatic erythroderma (PsE). The results were published in the British Journal of... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 6, 2016 Category: Dermatology Source Type: news
VIDEO: Secrets of success in a MACRA-based world
WASHINGTON – Are you ready for the way you are paid for seeing patients to change, and not just change, but change dramatically?
The value-based care system of reimbursement for primary care physicians under the Medicare Access and CHIP Reauthorization Act (MACRA) is expected to take effect... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 5, 2016 Category: Dermatology Source Type: news
VIDEO: Value-based care 101
WASHINGTON – Feel free to continue operating under a fee-for-service system, but according to Neil Kirschner, Ph.D., the senior associate for regulatory and insurer affairs at the American College of Physicians, “It’ll slowly be bled. The updates will be less, and will be linked to quality and... (Source: Skin and Allergy News)
Source: Skin and Allergy News - May 5, 2016 Category: Dermatology Source Type: news
